RNXT vs ZTS · rev $1.5M vs P/E 25, rev $2.47B
RenovoRx Inc (RNXT) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported RNXT revenue for 2026-06-30 was $1.5M. Net income was -$6.4M. RNXT currently screens at market cap $47.0M.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
RNXT currently screens at market cap $47.0M. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the RNXT and ZTS stock pages for the full models.
Not investment advice.